Behavioral Health Business December 13, 2023
Virtual substance use disorder (SUD) provider PursueCare netted $20 million in a series B fundraising round.
The Middletown, Connecticut-based company also acquired three software-based digital therapeutics developed by Pear Therapeutics, which filed for bankruptcy in April 2023. Pear’s SUD–focused prescription digital therapeutic (PDT) reSET landed an FDA de novo in 2017.
PursueCare previously offered digital therapeutics reSET, reSET-O and reSET-A to its patients before Pear’s bankruptcy. Patients were upset when they lost access to the products, Nick Mercadante, CEO and founder of PursueCare, told Behavioral Health Business.
“We knew that we had to solve for that gap,” Mercadante said. “So when the products became available, the stars aligned.”
The products can be used as self-guided cognitive behavioral therapy...
Today's Sponsors
Today's Sponsor